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Abstract A Ca2+ channel a,-subunit derived from rabbit heart was transiently expressed in COS-7 cells. The dihydropyridine (+)-isradipine had 
low affinity (K, = 34.3 nM) for the a,-subunit in the absence of the B-subunit due to rapid dissociation (k-, = 0.11 min-‘). Co-expression of the 
p-subunit resulted in a > 35-fold increase in (+)-isradipine binding affinity (K, = 0.9 nM) due to decreased issociation (k_, of 0.007 min-‘). Higher 
DHP binding affinity was associated with an increase of the apparent affinity of Ca’+ ions for the channel. Our data suggest hat thep-subunit affects 
the coordination of Ca’+ ions with sites that are coupled to the dihydropyridine binding domain and by this mechanism increases the affinity for 
these ligands. 
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1. Introduction 
Voltage-dependent Ca2’ channels in vertebrates are heterool- 
igomeric complexes, which consist of the major a,-subunit 
along with up to three accessory subunits a,6, /I, and (in skeletal 
muscle) y [1,2]. Sharing common structural motifs with the 
principal subunits of voltage-gated Na’- and K’-channels, the 
a,-subunit contains basic functional elements including the se- 
lectivity filter and the voltage sensor [3]. The a,-subunit of 
L-type Ca’+ channels also bears the domains responsible for 
Ca”-dependent binding of organic Ca” channel blockers, such 
as dihydropyridines, phenylalkylamines and benzothiazepines 
[4]. The site of non-covalent interaction with B-subunits has 
been identified as a 18-amino-acid motif within the intracellular 
linker between the transmembrane repeats I and II [5]. 
The functional role of the accessory subunits is not fully 
established. When co-expressed with a, in heterologous expres- 
sion systems (Xenopus oocytes or mammalian cells) a2-6 and y 
exert only minor effects on current densities, gating properties 
and drug binding [1,6]. In contrast, more pronounced effects 
have been reported for B-subunits. Their expression stabilized 
physiological Ca2’ channel kinetics [7,8] and increased a,-medi- 
ated inward currents [9,10]. The latter effect was explained by 
a facilitation of channel opening upon membrane depolariza- 
tion rather than an increased expression of a, protein in the 
plasma membrane [ 11,121. In addition, p-subunits enhance the 
expression of a,-associated DHP binding activity [9]. Radioli- 
gand binding studies in membranes prepared from stably trans- 
fected cell lines are consistent with an increase of the number 
of high affinity DHP binding sites without effects on the equi- 
librium dissociation constant of drug binding [7,8,12]. 
Here we report a more detailed analysis of the B-subunit 
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effects on the DHP binding properties of al-subunits tran- 
siently expressed in COS-7 cells. In contrast to the studies 
employing stably transfected cell lines we find that B-subunits 
do not affect DHP binding densities but are required to stabi- 
lize the DHP binding domain in a high affinity state. In kinetic 
experiments we provide evidence that this affinity increase is 
accompanied by an increased affinity of the a,-subunit for Ca” 
ions. Our data suggest hat ag-subunit-induced conformational 
change results in an improved coordination of Ca” within one 
or more of the channel’s Ca” binding domains. 
2. Materials and methods 
2.1 Construction of expression plasmids and transfection 
Plasmid c,CaCHZa was constructed by replacing the first 144 amino 
terminal residues of al,, (CaCHZa) [13] with the corresponding 60 
residues from carp skeletal muscle a, [14]. When expressed in yeast his 
construct yielded higher expression levels than CaCH2a cDNA (unpub- 
lished). For reasons of simplicity we refer to this expression-optimized 
construct as ‘a,’ in the text. The S-noncoding region of PCR amplified 
B-subunit cDNA derived from rabbit skeletal muscle @/CaBI) was 
supplemented with a consensus equence for initiation of translation 
[15] as reported to be essential for functional heterologous expression 
of cardiac B-subunits [IO]. The PCR-clone was sequenced on both 
strands and proven to be identical to the published original clone 
/3,/CaBI [16]. 5’-modified cDNAs were cloned into the SV40 late pro- 
moter expression vector pSVL (Pharmacia). Large-scale plasmid prep- 
aration and purification was performed using QUIAGEN-tips 
(QUIAGEN Inc.). COS-7 cells (ATCC CRL 165i) were transfected 
following a modified DEAE-Dextran protocol [17] using 4 fig of 
c,CaCHZa- and 1 pg of jI,-cDNAs per loo-mm dish. 
2.2 Membrane preparation and DHP binding assay 
55 hours after transfection cells were washed with PBS (145 mM 
NaCI, 2.68 mM KCI, 8.1 mM Na,HPO,. 12H,O, 1.47 mM KH,PO,), 
suspended (1 x IO6 cells/ml) in ice-cold hypotonic lysis buffer (10 mM 
Tris-HC1 (pH 7.4), 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 30 
PM CoCl,, 1 mg/ml bovine serum albumin (fatty acid free, Sigma)), and 
incubated on ice for 15 min. All further steps were carried out at 24°C. 
The swollen cells were disrupted with a glass-teflon homogenizer (tight 
pestle, 20 strokes). The homogenate was centrifuged for 15 min at 
400 x g. The low speed pellet was discarded and membranes in the 
supernatant collected by centrifugation at 90,000 x g for 45 min. The 
final pellet was resuspended inbinding buffer at a protein concentration 
of 3-6 mg/ml, quickly frozen in liquid nitrogen and stored for up to 4 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(94)00938-4 
142 J.Mitterdorfer et al. IFEBS Letters 352 (1994) 141-145 
weeks at -SOT until use. Guinea-pig cardiac membranes were pre- separated by filtration over GF/C glass fibre filters using 10% (w/v) 
pared as described [18]. Binding assays were carried out in 50 mM polyethylene glycol 6000, 10 mM Tris-HCI, pH 7.4, 10 mM MgCI, as 
Tris-HCI (pH 7.4 (25”C)), 0.1 mM PMSF, 1 mM CaCl,, 1 mg/ml bovine the washing buffer. All experiments, unless noted otherwise, were per- 
serum albumin (binding buffer) in a final assay volume of 0.505 ml. For 
inhibition and kinetic studies 0.3-1.4 nM of (+)-[‘Hlisradipine (83-88 
formed at least three times employing membranes from different trans- 
fections. Kd and B,,,, values were calculated after Scatchard transfor- 
Wmmol, New England Nuclear, Vienna, Austria) were incubated with mation. K, values were calculated as K, = IC,, I (1 + L/K,), where L is 
SO-150 pg of membrane protein for 60 min at 25°C (37°C for guinea- the radioligand concentration, Kd the dissociation constant and the IC, 
pig cardiac membranes) in the absence (control) and presence of 1 PM value the concentration of unlabeled ligand that inhibits specific bind- 
(f)-isradipine. Specifically bound radioligand at equilibrium was 3-7 ing by 50% [19]. Dissociation rate constants were determined by linear 
pM for a, (concentration of total ligand between 0.4 nM and 1.4 nM, regression analysis of semi-logarithmic plots of the pooled dissociation 
lOO-15Opg of membrane protein) and 12-20 pM for a,/3 (concentration data as shown in Fig. 2. In case of biphasic dissociation the rate con- 
of total ligand between 0.3 and 0.8 nM, 8&l 10 pg of membrane pro- stants were determined by nonlinear curve fitting of the pooled dissoci- 
tein) and guinea-pig cardiac membranes (concentration of total ligand ation data to a bi-exponential decay as shown in Fig. 3; the percentage 
0.3 nM, 4&60 pg of membrane protein). Bound and free ligand were of sites contributing to the respective rate is given in parenthesis. 
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Fig. 1. Co-expression of the B-subunit increases the DHP affinity of the a,-subunit. (A) Immunoblot analysis of a,-subunit expression in transfected 
COS-7 cells. Membrane preparation and immunoblotting was carried out as described in section 2. Membrane proteins (35 pug each) from COS-7 
cells transfected with c,CaCHta (lanes 1,2), c,,CaCH2a plus /I, (lane 3) and /Y, alone (lane 4) were immunostained with the affinity-purified 
sequence-directed antibody anti-CP(1382-1400). Nonspecific staining (lane I) was determined by pre-blocking affinity purified anti-CP(l382-1400) 
with 1 PM of the antigenic peptide. (B) Representative saturation isotherm of (+)j3H]isradipine binding to membranes from COS-7 cells transfected 
with c,CaCH2a in combination with /I, (0). Kd and B,,,,, values for the experiment shown were 0.69 nM and 256 fmoVmg of protein, respectively, 
as calculated after Scatchard transformation (r = 0.95). (+)-[‘HlIsradipine binding to membranes from COS-7 cells transfected with c,,,CaCH2a alone 
(0). Each data point represents the mean of three independent determinations. (CD) Stereospecific inhibition of (+)-[‘Hlisradipine binding to 
membranes from COS-7 cells transfected with c&aCH2a (C) or c,CaCH2a plus B, cDNA (D) by (+)-isradipine (0) and (-)-isradipine (0). Data 
were normalized with respect o control binding (= 100%). Error bars indicate S.D. from three separate transfections. The K, values for (+)-isradipine, 
calculated as described in section 2, are 34.3 f 6.9 nM (nH = 0.8) for a,, and 0.9 + 0.2 nM (nu = 1.0) for a#. No stereospecific binding was detected 
in nontransfected COS-7 cells (n = 2) and COS-7 transfected with or B, cDNA or vector DNA (n = 2). 
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2.3 Immunoblotting analysis 
Samples were reduced in the presence of 10 mM dithiothreitol, 
separated by electrophoresis through 8% SDS-polyacrylamide geland 
blotted to Immobilon-P membranes (Millipore) by wet electrophoretic 
transfer [20]. The membrane was blocked for 180 min with 0.05% 
gelatine, 0.25% non-fat milk in 20 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, 0.1% Tween-20, 0.5% Triton X-100. Binding of affinity purified 
anti-CP(1382-1400) 1211 was visualized using alkaline-phosphatase- 
conjugated goat anti-rabbit immunoglobulin~s and nitroblue tetra- 
zolium salt I 5-bromo-4-chloro-3-indolyl phosphate [20]. Prestained size 
markers were from Bio-Rad. 
3. Results and discussion 
COS-7 cells were transiently transfected with a,-subunit 
cDNA alone or in combination with skeletal muscle p-subunit 
cDNA. Immunoblot analysis (Fig. IA) revealed that the density 
of a, is not altered by co-expression of p-subunit. Equilibrium 
saturation experiments with the DHP antagonist (+)-[3H]israd- 
ipine were performed to assess dissociation constants and re- 
ceptor densities. Co-expression of the a,- and p-subunit yielded 
saturable high affinity DHP binding (& = 0.66 f 0.03 nM; 
B = 220 + 38 fmol/mg of protein). DHP binding to mem- 
brl;es of COS-7 cells transfected with the a,-subunit alone 
appeared to be unsaturable up to radioligand concentrations 
of 10 nM (Fig. 1B). We therefore tested whether the criteria of 
DHP binding to Ca” channels (nanomolar affinity, stereoselec- 
tivity) were met, by performing binding-inhibition experiments 
with the enantiomers of unlabeled isradipine. Inhibition of (+)- 
[3H]isradipine binding was stereoselective for the (+)- and (-)- 
enantiomer with eudismic ratios of -20 for a, and -100 for a#. 
The Ki value was 34.3 + 6.9 nM for (+)-isradipine when a, was 
expressed alone (Fig. 1C). Scatchard transformation of the 
binding-inhibition data in Fig. 1C yielded Bmax estimates z 411 
fmol/mg of protein (n = 3), suggesting that the B,, is not re- 
duced in the absence of p. As expected, co-expression of 
B- subunit decreased the Ki value for (+)-isradipine approxi- 
mately 38-fold to 0.9 f 0.2 nM (Fig. 1D). These data from 
binding-inhibition experiments confirm our results from direct 
labeling studies indicating that reduced binding of isradipine in 
the absence of/?-subunit is due to a decrease in affinity without 
major changes in B,,. We further confirmed this p-subunit- 
induced increase in affinity in kinetic experiments (Fig. 2). (+)- 
[3H]isradipine rapidly dissociated with a half-life of 6.5 min 
(k_, = 0.11 min-‘) when a, was expressed alone. Co-expression 
of p-subunit increased the half-life of the DHP-a, complex to 
99 min (k_, = 0.007 min-‘). As Kd = k-,/k_, calculated associa- 
tion rate constants must remain almost unchanged, suggesting 
that the B-subunit-induced increase in affinity can be attributed 
mainly to a decrease of the DHP dissociation rate. Thus our 
data, obtained from transient expression experiments, demon- 
strate that co-expression of B-subunit affects the affinity (&) 
and not the density (B,,,k, of DHP receptors. 
Since high affinity DHP binding is dependent on the occupa- 
tion of high affinity Ca” binding sites of the Ca” channel 
[22-261 we tested the possibility that the low DHP affinity 
observed for a, expressed alone was accompanied by a lower 
affinity for Ca”. It has previously been shown that ligand- 
channel complexes are destabilized when free Ca*’ is reduced 
below micromolar concentrations, resulting in a time- and tem- 
perature-dependent ligand dissociation, that is determined by 
the conversion rate of the channel to a very low affinity binding 
state [24]. This process is reversed by readdition of Ca*’ [22,24] 
and the conversion rates, monitored by ligand dissociation 
from the low affinity state, have been suggested to reflect Ca*’ 
dissociation from the channel [27]. In order to compare the 
conversion rate constants of a, and a# we performed kinetic 
experiments where dissociation of (+)-[3HJisradipine binding 
was induced by reducing the free Ca*’ concentration below 10 
nM by the addition of 10 mM EDTA. At 25°C a conversion 
rate constant of 2.16 min-’ for the a,-subunit was observed 
(Fig. 3). Co-expression of /I-subunits slowed the conversion 
induced by removal of free Ca*’ and resulted in a biphasic 
decay of (+)-[3H]isradipine binding (Fig. 3). Both rate constants 
(0.73 min-’ for the fast (27%), and 0.014 min-’ for the slow 
(73%) component) were substantially slower (3- and 150-fold, 
respectively) than the constant for a, expressed alone. The 
biphasic decay of (+)-[3H]isradipine binding prompted us to 
perform equivalent experiments with guinea-pig cardiac mem- 
branes. The conversion reaction was also biphasic (rate con- 
stants of 0.43 mm-’ (35%) and 0.014 min-’ (65%)), similar to 
the co- transfected COS-7 cells (Fig. 3, inset). This suggests that 
a,/9 expressing COS-7 cells reflect the behaviour of the entire 
(a,, B, a,$) membrane-bound channel with respect to Ca*’ 
binding at millimolar concentrations. 
We summarize our data as follows: 
(1) Co-expression of the B-subunit increases the affinity of 
the a,-subunit for DHP binding without increasing the number 
of DHP binding sites. This result is supported by the analysis 
of a,-mediated Ca*’ currents of cardiac a, expressed in Xenopus 
oocytes [l l] or CHO cells [12], showing that the density of 
a,-subunits is not altered by co-expression of B-subunit. Low 
affinity DHP binding to a,-subunits expressed alone is in con- 
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Fig. 2. Dissociation kinetics of (+)-PH]isradipine binding to membranes 
from COS-7 cells transfected with c,CaCH2a cDNA alone or in com- 
bination withp, cDNA. After 60 m&-incubation with (+)-[3H]isradipine 
the forward reaction was blocked by addition of 1 ,uM (f)-isradipine 
at the times indicated. The dissociation rate constants (k_,), calculated 
as described in section 2, were 0.11 + 0.01 min-’ for cc, (o), and 
0.0076 + 0.0027 min-’ for a,j3 (0). B, = specifically bound ligand at 
dissociation time t, B, = specifically bound ligand at equilibrium 
(t = 0). Each data point represents the mean of three independent deter- 
minations. 
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Fig. 3. Co-expression of the B-subunit increases the Ca*’ affinity of the 
a,-subunit. After 60 min incubation with (+)-[‘Hlisradipine reduction 
of total Ca*’ to < 10 nM was initiated by addition of 10 mM EDTA 
and specifically bound radioligand was measured at the times indicated. 
The conversion rate constant was 2.16 min-’ when a, was expressed 
alone (0). The conversion rate constants obtained for a,/I (0) were 0.73 
min-’ (27%) and 0.014 min-’ (73%) for the fast and slow component, 
respectively. The lines represent logarithmic transformation of the 
curves obtained by nonlinear fitting. Inset: data obtained with guinea- 
pig cardiac membranes (n = 2) are depicted. Two components (0.43 
min-’ (35%) and 0.014 min-’ (65%)) of EDTA-induced decay of (+)- 
[‘Hlisradipine binding were observed. Each data point represents the 
mean of three independent determinations. 
trast to the findings from cell lines stably transfected with var- 
ious q-subunits [7,12,28-301. This contradiction might arise 
from the intrinsic difference between stable and transient ex- 
pression. In transient expression experiments a population of 
cells is examined whereas in an approach for stable expression 
individual clones are selected for specific channel properties, 
such as high affinity DHP binding. Endogenous expression of 
p-subunit, which is not detected by PCR, Northern- and West- 
ern-blot analysis (due to low density and/or sequence diver- 
gence with the probes used), could therefore become an invol- 
untary selection criterion and account for the stabilization of 
a small portion of expressed a,-subunits in the high affinity 
DHP binding state. Subsequent co-expression of /?-subunits 
would then result in an increase of functional, high affinity 
DHP receptors (i.e. an increase in B,,,). 
(2) Based on the model of interdependence between Ca” and 
DHP binding [31] our results indicate that the B-subunit has a 
crucial influence on the affinity of Ca*’ sites coupled to the 
DHP binding domain. This is evident from the fact that co- 
expression ofp-subunit restores the biphasic conversion behav- 
iour of the membrane-bound channels from heart. At present 
we are unable to predict which of the two proposed Ca*’ bind- 
ing sites of the a,-subunit [32,33] are involved in this phenom- 
enon. Site-directed mutagenesis will help to resolve this issue. 
The most likely candidate is the Ca*’ binding site near the DHP 
binding domain. This domain has been localized in the P-re- 
gions of repeats III and IV [34] and encompasses two of the four 
glutamate residues which form the Ca” coordination sites of 
the pore [33,35-371. As a working hypothesis we would like to 
propose that the p-subunit conformationally stabilizes these 
Ca*’ coordination sites and, in turn, increases the affinity by 
which dihydropyridines can bind. 
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